Skip to main navigation
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT7732 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
SMARCA Educational Video Series
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quotes & Charts
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor FAQ's
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
Contact IR
We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT7732 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
SMARCA Educational Video Series
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quotes & Charts
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor FAQ's
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact
Name
Email
Subject
Comments
Leave this field blank
Print Page
RSS Feeds
Email Alerts
Search
About
Overview
Leadership
Board of Directors
Science
Overview
Pipeline
SMARCA2
CDK9
Precision ADCs
Discovery Engine
Publications
Clinical Trials
Overview
PRT3789 Trials
PRT2527 Trials
PRT7732 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
SMARCA Educational Video Series
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quotes & Charts
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor FAQ's
Contact IR
Email Alerts
News
Life at Prelude
Overview
Open Positions
Contact